HPTN

New PrEP Study Shows Significant Results for HIV Prevention

New PrEP Study Shows Significant Results for HIV Prevention

Researchers from the HIV Prevention Trials Network (HPTN) announced today that the HPTN 083 clinical trial showed that a pre-exposure prophylaxis (PrEP) regimen containing long-acting cabotegravir (CAB LA) injected once every eight weeks was superior to daily oral...
ICAP to Test New Combinations of Antibodies for HIV Prevention

ICAP to Test New Combinations of Antibodies for HIV Prevention

ICAP at Columbia University is playing a key role in testing the feasibility of a potential breakthrough in the global effort to stop HIV transmission. The Harlem Prevention Center, one of ICAP’s two clinical research centers in New York, is participating in a...
1 2
X